HomeMarketBristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma Posted in MarketBristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma March 20, 2026 Reporter Bristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma Source link